Ryan Specialty Holdings Inc. (NYSE:RYAN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $59.00.
Several equities research analysts recently weighed in on RYAN shares. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, February 13th. Weiss Ratings lowered Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, February 5th. Mizuho set a $53.00 price target on Ryan Specialty in a research note on Friday, February 13th. Jefferies Financial Group began coverage on Ryan Specialty in a report on Monday, December 1st. They set a “hold” rating and a $64.00 price target on the stock. Finally, BMO Capital Markets reduced their price objective on Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating for the company in a report on Monday, November 3rd.
Check Out Our Latest Research Report on Ryan Specialty
Ryan Specialty Price Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings data on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The firm’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 earnings per share. Sell-side analysts predict that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 24th will be paid a $0.13 dividend. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Tuesday, February 24th. Ryan Specialty’s dividend payout ratio (DPR) is presently 123.81%.
Insider Activity at Ryan Specialty
In other news, CEO Timothy William Turner sold 129,570 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the transaction, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. This trade represents a 91.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were purchased at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the purchase, the director owned 428,295 shares in the company, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 52.21% of the company’s stock.
Institutional Trading of Ryan Specialty
Large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in Ryan Specialty by 10.6% during the first quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock valued at $4,406,000 after buying an additional 5,739 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Ryan Specialty by 25.1% during the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock valued at $367,000 after acquiring an additional 998 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Ryan Specialty by 46.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Ryan Specialty by 11.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares during the period. Finally, Allianz Asset Management GmbH lifted its position in Ryan Specialty by 55.7% during the second quarter. Allianz Asset Management GmbH now owns 12,297 shares of the company’s stock valued at $836,000 after purchasing an additional 4,400 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Featured Stories
- Five stocks we like better than Ryan Specialty
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This makes me furious
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
